ULTIo — Ultimovacs ASA Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro CapNeutral

Annual balance sheet for Ultimovacs ASA, fiscal year end - December 31st, NOK millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	405	448	579	430	270
Net Total Receivables	0.564	0.749	1.14	1.28	1.1
Prepaid Expenses
Total Other Current Assets
Total Current Assets	408	449	582	436	272
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	4.06	4.01	2.16	5.66	3.67
Net Goodwill
Net Intangible Assets
Other Long Term Assets
Total Assets	478	530	656	510	349
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	20.3	27.5	50.9	45.9	56.1
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Liabilities	33.4	41.3	62.4	60.3	69.6
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	445	488	593	449	279
Total Liabilities & Shareholders' Equity	478	530	656	510	349
Total Common Shares Outstanding